Business Context and Reporting Period
This Form 8-K filing by Acadia Healthcare Company, Inc. reports on events occurring on February 13, 2014, and a press release issued on February 19, 2014. The primary event is the entry into a Fourth Amendment to the Company's Amended and Restated Credit Agreement. The filing also references the Company's operating and financial results for the fourth quarter and full year ended December 31, 2013, though specific financial figures are contained in an incorporated press release rather than the text of this report.
Key Financial Metrics and Debt Structure
The Fourth Amendment significantly altered the Company's debt facility structure and terms:
- Facility Size: Increased to a revolving line of credit of up to $300.0 million and term loans of $300.0 million.
- Incremental Capacity: Added a $150.0 million incremental credit facility, with potential for unlimited additional amounts subject to financial ratios.
- Maturity Date: Extended to February 13, 2019.
- Interest Rates: Reduced by 0.50% for LIBOR Rate Loans and 0.10% for the Unused Line Fee. Rates are tiered based on the consolidated leverage ratio.
- Principal Repayment Schedule (Term Loans):
- 2014: $1.9 million per quarter
- 2015: $3.8 million per quarter
- 2016: $5.6 million per quarter
- 2017: $7.5 million per quarter
- 2018: $9.4 million per quarter
- Remaining balance due at maturity in 2019.
The filing text does not provide specific values for revenue, profit, cash flow, or current liquidity positions; these are referenced only as being available in the attached press release (Exhibit 99).
Material Changes Versus Prior Period
The material change reported is the restructuring of the Senior Credit Facility. Key modifications include:
- Increased Capacity: Expansion of both revolving and term loan limits.
- Cost Reduction: Lower interest rate spreads and unused line fees compared to the prior agreement.
- Covenant Flexibility: Adjustments to financial covenants, specifically the maximum consolidated leverage ratio, which is now permitted to be as high as 5.50:1.0 through 2014, stepping down to 4.50:1.0 by March 31, 2017.
- Extended Maturity: Pushed the final maturity date to 2019.
Guidance, Risks, and Covenants
Financial Covenants: The Company must maintain specific ratios to avoid default:
- Fixed Charge Coverage Ratio: Must not be less than 1.25:1.00 at the end of any fiscal quarter.
- Consolidated Leverage Ratio: Maximum of 5.50:1.00 through 2014, decreasing to 5.25:1.00 in 2015, 5.00:1.00 in 2016, and 4.50:1.00 thereafter.
- Consolidated Senior Secured Leverage Ratio: Maximum of 3.50:1.00 through 2014, decreasing to 3.25:1.00 in 2015, and 3.00:1.00 thereafter.
Risks and Restrictions:
- Default Consequences: A breach of covenants could trigger a cross-default under other debt agreements, potentially requiring immediate repayment of all indebtedness.
- Dividend Restrictions: The Company is generally prohibited from issuing dividends or distributions, with limited exceptions for tax distributions, employee equity repurchases (capped at $500,000/year), and merger-related payments.
- Capital Expenditures: Limited to 10.0% of total revenues.
Investor Verification Checklist
- Verify the specific Q4 and full-year 2013 revenue, EBITDA, and cash flow figures in the press release (Exhibit 99) to assess compliance with the new leverage covenants.
- Confirm the current consolidated leverage ratio to ensure it remains below the 5.50:1.00 threshold for the first quarter of 2014.
- Review the "incremental credit facility" terms to understand the specific financial ratios required to access the additional $150.0 million.
- Monitor the Company's capital expenditure plans to ensure they do not exceed 10.0% of total revenues.
- Assess the impact of the extended maturity date (2019) on the Company's long-term liquidity strategy.